
Kwick Forensic IPO
What the filing actually says
Our read of the offer document and the exchange data — not the issuer's summary of itself
The disclosed numbers are strong — 3 of 3 signals read positive
- Undemanding valuation11.3× earnings at the upper band, with no peer set published to compare against
- Conservative balance sheetDebt/equity of 0.00×
- Institutions bid heavilyQIB portion subscribed 224.32×
Every line above is arithmetic on a figure shown elsewhere on this page - no model, no opinion. It describes the quality of the offering as disclosed, and is pulled toward neutral to reflect how much the document leaves unsaid. It is not a prediction of the listing price, and it is not advice to apply.
Dates
The issuer's tentative timetable — a date passing is not confirmation the step completed
- Opens27 Aug 2026
- Closes31 Aug 2026
- Allotment01 Sept 2026
- Listing03 Sept 2026
Demand and your odds
How the book filled, and what that means for an application
2,18,222 applications received — how many people bid, as opposed to how much money did. Exchange figures as of 31 Aug 2026.
Retail is 313.18× subscribed. Allotment is a lottery on a single lot, so roughly 1 in 313.2 applications gets one lot. Bidding for extra lots does not improve these odds.
HNI is 318.53× subscribed. This category is allotted proportionately, so a bid receives roughly 1/318.5 of the shares applied for, subject to the minimum-lot draw.
Derived from SEBI's allotment mechanics and the subscription figures beside it. Retail allotment is a lottery on a single lot, so applying for more lots does not improve your chance of getting something.
Grey market premium
Unofficial dealer quotes — not published by NSE, BSE, SEBI or the company
What this number is not. Grey-market premium is an unregulated, thinly-traded quote from private dealers. It is not a forecast of the listing price, it is not verifiable, and it can be moved by the same people who benefit from it looking high. We publish it because you will look it up anyway — and we deliberately do not convert it into an expected listing gain, because that arithmetic implies a reliability the number has never earned. For what actually happened to comparable issues, see recent outcomes below.
The offering
Terms, structure and who is selling
Who gets what
How the issue is split between investor categories, and what each may bid.
| Category | Shares | % of issue |
|---|---|---|
| QIB | 26,73,600 | 47.39% |
| Anchor Investor | 16,03,200 | 28.42% |
| QIB (Ex. Anchor) | 10,70,400 | 18.97% |
| NII (HNI) | 8,06,400 | 14.29% |
| bNII > ₹10L | 5,37,600 | 9.53% |
| sNII < ₹10L | 2,68,800 | 4.76% |
| Retail | 18,78,400 | 33.30% |
| Market Maker | 2,83,200 | 5.02% |
Total issue 56,41,600 shares. Indented rows sit inside the category above them and are not added to it.
Lot size alone does not answer "how much do I need" — an S-HNI minimum is several lots, not one.
Anchors are institutional money placed a day before bidding opens, against a lock-in. Those two dates are when that stock can first be sold — a supply event worth knowing if you still hold.
What the money is for
Stated use of the net proceeds
- 01Funding the Working Capital requirement of our Company₹31.42 Cr
- 02General Corporate Purposes₹4.65 Cr
Risks worth reading
Ranked by our severity assessment, not by the order the prospectus prints them
mediumOur products and services are significantly concentrated in the states of Bihar and Gujarat. Any adverse developments in these regions may materially impact our business, financial condition, results of operations, and cash flows.
mediumWe do not have long-term agreements with a majority of our customers. Any changes or cancellations to our orders or our inability to forecast demand for our products may adversely affect our business, results of operations and financial condition.
mediumWe derive a major portion of our revenue from a few customers. The loss of this significant or key customer or a reduction in the amount of business could have an adverse effect on our business, results of operations, financial condition and cash flows.
Except as stated in this section, as on the date of this Prospectus, there are no outstanding: (i) criminal proceedings; (ii) actions by statutory or regulatory authorities; (iii) claims relating to direct and indirect taxes; (iv) disciplinary actions including penalties imposed by SEBI or stock exchanges against the Promoters in the last five financial years, including outstanding action; or (v) details of any other pending material litigation (as defined below); involving our Company, its Directors and Promoters (collectively, the “Relevant Parties”) (vi) all criminal proceedings and actions taken by regulatory authorities and statutory authorities against such key managerial personnel and senior management of our Company. As per the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended from time to time, all other pending civil litigations shall be classified as ‘material’ based on the lower of the threshold criteria mentioned below - (a) Two percent of turnover, as per the latest annual restated financial statements i.e. amounting to ₹ 211.43 Lakhs; or (b) Two percent of net worth, as per the latest annual restated financial statements, except in case the arithmetic value of the net worth is negative i.e. amounting to ₹ 82.81 Lakhs; or (c) Five percent of the average of absolute value of profit or loss after tax, as per the last three annual restated financial statements i.e. amounting to ₹ 41.50 Lakhs; Accordingly, our Board, in its meeting held on May 25, 2026 considering the aforesaid limits mentioned in clause (a) to (c) in consideration the lowest threshold in terms of value or expected impact as 5% (five percent) of the average of absolute value of profit or loss as per the last three annual restated financial statements (disregarding the ‘sign’ (positive or negative) that denotes such value as the said value / figure) being ₹ 41.50 Lakhs . Accordingly, the other pending civil litigation shall be considered Material in the Issue Documents if: a) the aggregate amount involved in such individual litigation exceeds ₹ 41.50 Lakhs; or b) where the decision in one litigation is likely to affect the decision in similar litigations, even though the amount involved in such single litigation individually may not exceed five percent of the average value profit or loss after tax of the Company, as per the last three annual restated consolidated financial statements; or; or c) any such litigation the monetary liability is not quantifiable, or which does not fulfill the threshold specified in (a) above, but the outcome of which could, nonetheless, have a material adverse effect on the Business, Operations, Performance, Prospects, Financial position or reputation of our Company. The Company has a policy for identification of Material Outstanding Dues to Creditors in terms of the SEBI (ICDR) Regulations, 2018 as amended for creditors where outstanding due to any one of them exceeds Five percent of the trade payables of the Company as per the last audited financial statements of the Company included in the Draft Issue Document and Issue Document.
Positives the filing discloses (2)
84% of the offer is fresh issue, so most proceeds fund the company.
Debt-to-equity of 0.00x.
What happened to comparable issues
The last 8 issues to list with a recorded opening price, most comparable first
Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.
About Kwick Forensic
Kwick Forensic Solutions is a provider of products, solutions, and technologies for forensic sciences, fingerprint science, cyber and digital forensics, DNA forensics, social media analytics and big data analytics, primarily for law enforcement and forensic investigation applications. The company supplies forensic science and physical evidence solutions, including fingerprint and evidence collection kits, handheld forensic devices and laboratory equipment, mobile crime scene investigation vehicles, cyber and digital forensic tools, and DNA forensic solutions. The company also provides forensic equipment on a rental or sublease basis, including handheld liquor-detection scanners and other detection, scanning, and imaging systems, along with manpower support where required. Its customers include police stations, central and state forensic laboratories, fingerprint bureaus, crime investigation departments, police training academies, and universities offering forensic science courses. The company procures forensic products through a combination of domestic sourcing and imports, while certain forensic kits and handheld devices are assembled or developed in-house. Use of proceeds: The IPO consists of both a fresh issue of shares and an offer for sale. Proceeds from the OFS will go to the respective selling shareholders, whereas the net proceeds from the fresh issue will be used for the following purposes: Funding the working capital requirement of our company — Rs 31.42 crore General corporate purposes
Offer documents
The primary sources everything above is drawn from
Common questions
What is the Kwick Forensic IPO GMP today?
The most recent grey-market premium recorded for Kwick Forensic is ₹85 per share — about 94.4% over the ₹90 upper band. Grey-market premium is an unofficial, unregulated quote from private dealers. It is not published by NSE, BSE, SEBI or the company, and it is not a forecast of the listing price.
How many times is the Kwick Forensic IPO subscribed?
Kwick Forensic is subscribed 289.00× overall (QIB 224.32×, NII 318.53×, retail 313.18×). Subscription keeps changing until the issue closes; the final basis of allotment is published by the registrar, Bigshare Services Pvt Ltd.
What is the minimum investment in the Kwick Forensic IPO?
One lot is 1,600 shares, so a retail application at the ₹90 cut-off price blocks ₹1,44,000. Retail applications are capped at ₹2,00,000; above that you bid in the HNI category, where allotment is proportionate rather than by lottery.
What are the chances of allotment in the Kwick Forensic IPO?
The retail portion is subscribed 313.18×, so allotment is by lottery and the odds of receiving at least one lot are roughly 1 in 313. Applying for more lots does not improve the chance of getting something — every retail applicant competes for the same single minimum lot.
When is the Kwick Forensic IPO allotment date?
Allotment is scheduled for 2026-09-01, with listing on 2026-09-03. These dates are the issuer's tentative timetable — a date passing is not confirmation that the step completed. Allotment status is published by the registrar, Bigshare Services Pvt Ltd.
Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.

